MCQ Quiz: Ophthalmic Drug Delivery

Ophthalmic drug delivery focuses on administering medications to the eye to treat conditions such as infections, glaucoma, inflammation, and dry eye. Dosage forms include solutions, suspensions, ointments, gels, and ocular inserts. The unique anatomy and physiology of the eye present formulation and delivery challenges. This MCQ quiz covers formulation types, pharmacokinetics, ocular barriers, administration techniques, and therapeutic applications—ideal for Pharm.D. students.

1. Which of the following is an ophthalmic dosage form?

  • A. Intravenous injection
  • B. Oral tablet
  • C. Eye drop solution
  • D. Rectal suppository
    Correct answer: C. Eye drop solution

2. The main anatomical barrier for ophthalmic drug absorption is the:

  • A. Retina
  • B. Lens
  • C. Corneal epithelium
  • D. Iris
    Correct answer: C. Corneal epithelium

3. Eye drops are most commonly used for:

  • A. Skin infections
  • B. Eye conditions like conjunctivitis and glaucoma
  • C. Ear infections
  • D. Nasal congestion
    Correct answer: B. Eye conditions like conjunctivitis and glaucoma

4. The volume the conjunctival sac can hold without overflow is approximately:

  • A. 0.5 mL
  • B. 0.03 mL
  • C. 1 mL
  • D. 2 mL
    Correct answer: B. 0.03 mL

5. The major limitation of eye drops is:

  • A. Fast onset
  • B. Poor systemic absorption
  • C. Rapid drainage and short contact time
  • D. High protein binding
    Correct answer: C. Rapid drainage and short contact time

6. Which formulation stays in the eye longer than a solution?

  • A. Suspension
  • B. Ointment
  • C. Foam
  • D. Tablet
    Correct answer: B. Ointment

7. Ocular drug delivery aims to:

  • A. Treat systemic infections
  • B. Deliver drugs to the skin
  • C. Provide local treatment to the anterior segment of the eye
  • D. Replace ear drops
    Correct answer: C. Provide local treatment to the anterior segment of the eye

8. A major advantage of ophthalmic ointments is:

  • A. Immediate vision clarity
  • B. Extended contact time
  • C. High systemic absorption
  • D. Pleasant taste
    Correct answer: B. Extended contact time

9. Eye suspensions must be:

  • A. Injected
  • B. Shaken before use
  • C. Heated before application
  • D. Inhaled
    Correct answer: B. Shaken before use

10. The pH of ophthalmic formulations should be:

  • A. 1–2
  • B. 7–9
  • C. Close to tear fluid pH (~7.4)
  • D. Alkaline (>9)
    Correct answer: C. Close to tear fluid pH (~7.4)

11. Ophthalmic inserts are:

  • A. Oral tablets
  • B. Rectal suppositories
  • C. Solid or semi-solid dosage forms placed in the conjunctival sac
  • D. Eye drops
    Correct answer: C. Solid or semi-solid dosage forms placed in the conjunctival sac

12. Which of the following is NOT suitable for ocular drug delivery?

  • A. Eye drops
  • B. Contact lens-type devices
  • C. Injectable gels
  • D. Vaginal rings
    Correct answer: D. Vaginal rings

13. Which enzyme in tears can degrade ophthalmic drugs?

  • A. Pepsin
  • B. Lipase
  • C. Lysozyme
  • D. Amylase
    Correct answer: C. Lysozyme

14. Ophthalmic formulations must be:

  • A. Hypotonic
  • B. Sterile
  • C. Injectable
  • D. Opaque
    Correct answer: B. Sterile

15. Which preservative is commonly used in ophthalmic preparations?

  • A. Ethanol
  • B. Chlorhexidine
  • C. Benzalkonium chloride (BAK)
  • D. Formaldehyde
    Correct answer: C. Benzalkonium chloride (BAK)

16. Preservative-free formulations are preferred for:

  • A. Single-use vials
  • B. Long-term therapy
  • C. Non-sterile solutions
  • D. Oral medications
    Correct answer: A. Single-use vials

17. Which class of drugs is commonly used in eye drops for glaucoma?

  • A. Antibiotics
  • B. Beta-blockers
  • C. Antihistamines
  • D. Steroids
    Correct answer: B. Beta-blockers

18. A major side effect of topical corticosteroids in the eye is:

  • A. Hypertension
  • B. Cataract formation
  • C. Hair loss
  • D. Constipation
    Correct answer: B. Cataract formation

19. For maximum absorption, eye drops should be instilled:

  • A. Into the outer eyelid
  • B. On the eyeball surface
  • C. Into the conjunctival sac
  • D. On the eyebrow
    Correct answer: C. Into the conjunctival sac

20. The ideal viscosity-enhancing agent for ophthalmic gels is:

  • A. Talc
  • B. Petrolatum
  • C. Carbomer or HPMC
  • D. Tween 80
    Correct answer: C. Carbomer or HPMC

21. The tear turnover rate in a normal eye is approximately:

  • A. 0.1 mL/min
  • B. 0.5 mL/min
  • C. 1.0 mL/min
  • D. 2.0 mL/min
    Correct answer: A. 0.1 mL/min

22. A “gel-forming” eye drop becomes viscous upon:

  • A. Freezing
  • B. Contact with tear fluid
  • C. Oral ingestion
  • D. High pH
    Correct answer: B. Contact with tear fluid

23. Why are ophthalmic solutions preferred over suspensions for initial therapy?

  • A. Lower cost
  • B. Better appearance
  • C. Faster absorption and ease of administration
  • D. Longer contact time
    Correct answer: C. Faster absorption and ease of administration

24. What is the purpose of a buffering agent in ophthalmic preparations?

  • A. Change color
  • B. Enhance aroma
  • C. Maintain pH for stability and comfort
  • D. Increase solubility
    Correct answer: C. Maintain pH for stability and comfort

25. The main route for systemic absorption of ophthalmic drugs is via the:

  • A. Iris
  • B. Sclera
  • C. Nasolacrimal duct
  • D. Retina
    Correct answer: C. Nasolacrimal duct

26. Which ophthalmic formulation is best for overnight use?

  • A. Eye drops
  • B. Ointments
  • C. Solutions
  • D. Suspensions
    Correct answer: B. Ointments

27. Cycloplegic agents are used in ophthalmology for:

  • A. Pain relief
  • B. Paralyzing accommodation during eye exams
  • C. Antifungal activity
  • D. Lowering IOP
    Correct answer: B. Paralyzing accommodation during eye exams

28. Artificial tears are used to treat:

  • A. Cataracts
  • B. Dry eye syndrome
  • C. Conjunctivitis
  • D. Glaucoma
    Correct answer: B. Dry eye syndrome

29. Prolonged use of ophthalmic steroids can lead to:

  • A. Tooth discoloration
  • B. Glaucoma and increased intraocular pressure
  • C. Migraine
  • D. Seizures
    Correct answer: B. Glaucoma and increased intraocular pressure

30. Which of the following eye conditions is treated with timolol drops?

  • A. Retinitis pigmentosa
  • B. Glaucoma
  • C. Cataract
  • D. Macular degeneration
    Correct answer: B. Glaucoma

31. Eye drop instillation should be followed by:

  • A. Drinking water
  • B. Nasal spray
  • C. Nasolacrimal occlusion for 1–2 minutes
  • D. Immediate eye rubbing
    Correct answer: C. Nasolacrimal occlusion for 1–2 minutes

32. The risk of systemic side effects from eye drops can be reduced by:

  • A. Increasing dose
  • B. Swallowing the drops
  • C. Applying digital pressure to nasolacrimal duct
  • D. Using two drops at once
    Correct answer: C. Applying digital pressure to nasolacrimal duct

33. Multidose ophthalmic products should contain:

  • A. Buffers
  • B. Viscosity enhancers
  • C. Preservatives
  • D. Enzymes
    Correct answer: C. Preservatives

34. Ophthalmic suspensions offer which advantage over solutions?

  • A. Faster onset
  • B. Prolonged drug release
  • C. Lower dose
  • D. Easier administration
    Correct answer: B. Prolonged drug release

35. The posterior segment of the eye includes the:

  • A. Conjunctiva
  • B. Cornea
  • C. Retina and vitreous humor
  • D. Iris
    Correct answer: C. Retina and vitreous humor

36. Drug delivery to the posterior segment is often achieved by:

  • A. Eye drops
  • B. Ointments
  • C. Intravitreal injection
  • D. Oral tablets
    Correct answer: C. Intravitreal injection

37. The term “mydriatic” refers to a drug that:

  • A. Lowers blood pressure
  • B. Dilates the pupil
  • C. Reduces tear production
  • D. Contracts the iris
    Correct answer: B. Dilates the pupil

38. Which eye condition involves increased intraocular pressure?

  • A. Conjunctivitis
  • B. Glaucoma
  • C. Uveitis
  • D. Cataract
    Correct answer: B. Glaucoma

39. The optimal drop size for ocular administration is approximately:

  • A. 0.1 mL
  • B. 0.03 mL
  • C. 1.0 mL
  • D. 5.0 mL
    Correct answer: B. 0.03 mL

40. Which of the following is contraindicated in fungal eye infections?

  • A. Natamycin
  • B. Fluconazole
  • C. Prednisolone acetate
  • D. Amphotericin B
    Correct answer: C. Prednisolone acetate

41. What is the typical shelf life of unopened ophthalmic solutions?

  • A. 1 week
  • B. 1 month
  • C. 1–2 years
  • D. 6 months
    Correct answer: C. 1–2 years

42. Which of the following is used to stain the cornea for diagnostic purposes?

  • A. Tropicamide
  • B. Fluorescein sodium
  • C. Brimonidine
  • D. Cyclopentolate
    Correct answer: B. Fluorescein sodium

43. Which ophthalmic antibiotic is safe in infants?

  • A. Ciprofloxacin
  • B. Gentamicin
  • C. Erythromycin ointment
  • D. Tetracycline drops
    Correct answer: C. Erythromycin ointment

44. Eye drops should be stored:

  • A. In the freezer
  • B. In direct sunlight
  • C. According to label instructions, often in a cool, dry place
  • D. On a radiator
    Correct answer: C. According to label instructions, often in a cool, dry place

45. Ultimately, ophthalmic drug delivery is designed to:

  • A. Replace systemic antibiotics
  • B. Provide targeted ocular therapy while minimizing systemic exposure
  • C. Treat skin diseases
  • D. Improve hearing
    Correct answer: B. Provide targeted ocular therapy while minimizing systemic exposure

46. Which of the following is used for local anesthesia in eye procedures?

  • A. Tetracaine
  • B. Pilocarpine
  • C. Timolol
  • D. Tropicamide
    Correct answer: A. Tetracaine

47. Which ophthalmic agent is used as a diagnostic to assess tear production?

  • A. Atropine
  • B. Schirmer strip
  • C. Pilocarpine
  • D. Brimonidine
    Correct answer: B. Schirmer strip

48. Ophthalmic ointments are best applied:

  • A. On the eyelid
  • B. Over the cornea
  • C. Into the lower conjunctival sac
  • D. In the ear canal
    Correct answer: C. Into the lower conjunctival sac

49. A common preservative-related side effect in ophthalmic products is:

  • A. Blurred vision
  • B. Ocular surface irritation
  • C. Increased intraocular pressure
  • D. Drowsiness
    Correct answer: B. Ocular surface irritation

50. Which formulation can offer controlled release over several hours or days in the eye?

  • A. Solution
  • B. Suspension
  • C. Ocular insert
  • D. Gel drop
    Correct answer: C. Ocular insert

Leave a Comment